Cite
Safety and effectiveness of monovalent COVID-19 mRNA vaccination and risk factors for hospitalisation caused by the omicron variant in 0.8 million adolescents: A nationwide cohort study in Sweden.
MLA
Nordström, Peter, et al. “Safety and Effectiveness of Monovalent COVID-19 MRNA Vaccination and Risk Factors for Hospitalisation Caused by the Omicron Variant in 0.8 Million Adolescents: A Nationwide Cohort Study in Sweden.” PLoS Medicine, vol. 19, no. 2, Feb. 2023, pp. 1–14. EBSCOhost, https://doi.org/10.1371/journal.pmed.1004127.
APA
Nordström, P., Ballin, M., & Nordström, A. (2023). Safety and effectiveness of monovalent COVID-19 mRNA vaccination and risk factors for hospitalisation caused by the omicron variant in 0.8 million adolescents: A nationwide cohort study in Sweden. PLoS Medicine, 19(2), 1–14. https://doi.org/10.1371/journal.pmed.1004127
Chicago
Nordström, Peter, Marcel Ballin, and Anna Nordström. 2023. “Safety and Effectiveness of Monovalent COVID-19 MRNA Vaccination and Risk Factors for Hospitalisation Caused by the Omicron Variant in 0.8 Million Adolescents: A Nationwide Cohort Study in Sweden.” PLoS Medicine 19 (2): 1–14. doi:10.1371/journal.pmed.1004127.